Name: UMIN ID:
Unique ID issued by UMIN | UMIN000006111 |
---|---|
Receipt number | R000007226 |
Scientific Title | Phase II trial of capecitabine + bevacizumab as maintenance treatment after initial treatment with XELOX in previously untreated metastatic colorectal cancer |
Date of disclosure of the study information | 2011/08/03 |
Last modified on | 2013/01/06 00:11:41 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/08/03 19:24:14 | ||
2 | Update | 2013/01/06 00:11:42 | Institute Institute Organization Organization |